ASCVD

Clinical trials for ASCVD explained in plain language.

Never miss a new study

Get alerted when new ASCVD trials appear

Sign up with your email to follow new studies for ASCVD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 3 Not yet finished but already full! 5 Completed 1

New pill aims to crush stubborn cholesterol in High-Risk patients

Disease control Completed

This study tested whether a new combination pill containing two drugs (obicetrapib and ezetimibe) could lower 'bad' cholesterol (LDL-C) more effectively than a placebo or either drug alone. It involved 407 adults with a genetic cholesterol disorder (HeFH) or established heart dis…

Matched conditions: ASCVD

Phase: PHASE3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

ASCVD

Get alerted when new ASCVD trials appear

New pill aims to crush stubborn cholesterol in High-Risk patients